ANEBULO PHARMACEUTICALS INC (ANEB) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:ANEB • US0345691036

0.8212 USD
-0.13 (-13.57%)
Last: Feb 5, 2026, 08:09 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ANEB revenue by date.ANEB revenue by date.
N/AN/AN/A
-100.00%		N/AN/AN/AN/A
159.56%		N/A
62.22%
EBITDA
YoY % growth
ANEB ebitda by date.ANEB ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ANEB ebit by date.ANEB ebit by date.
-170K-3.61M
-2,023.53%		-6.83M
-89.20%		-11.78M
-72.47%		-8.309M
29.47%		-9.224M
-11.01%		N/A
-60.98%		N/A
-20.00%		N/A
-15.68%		N/A
-15.89%		N/A
-20.73%		N/A
89.25%		N/A
1,429.00%		N/A
115.12%
Operating Margin
ANEB operating margin by date.ANEB operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ANEB eps by date.ANEB eps by date.
N/AN/AN/A
56.45%		-0.47
-70.66%		-0.32
31.91%		-0.26
18.75%		N/A
-88.31%		N/A
4.17%		N/A
-6.52%		N/A
430.61%		N/A
62.35%		N/A
35.36%		N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.13
-47.33%		-0.14
-257.00%		-0.10
-104.00%		-0.11
-124.40%		-0.11
15.38%		-0.12
14.29%		-0.13
-30.00%
Revenue
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-3.564M
-37.70%		-3.861M
-104.02%		-4.009M
-71.98%		-4.098M
-20.01%		-4.276M
-19.98%		-4.633M
-20.00%		-4.81M
-20.00%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2026
Q2Q % growth		 -0.05
37.50%		-0.120.0759.15%
Q4 2025
Q2Q % growth		 -0.05 -0.080.0338.73%
Q3 2025
Q2Q % growth		 -0.04
33.33%		-0.050.0121.57%
Q2 2025
Q2Q % growth		 -0.09
18.18%		-0.08-0.01-10.29%
Q1 2025
Q2Q % growth		 -0.08
20.00%		-0.05-0.03-56.86%
Q4 2024
Q2Q % growth		 -0.05
50.00%		-0.130.0862.44%
Q3 2024
Q2Q % growth		 -0.06
45.45%		-0.120.0650.15%
Q2 2024
Q2Q % growth		 -0.11
26.67%		-0.10-0.01-7.84%
Q1 2024
Q2Q % growth		 -0.10
9.09%		-0.120.0215.97%
Q4 2023
Q2Q % growth		 -0.10 -0.110.0111.41%
Q3 2023
Q2Q % growth		 -0.11
-37.50%		-0.160.0531.31%
Q2 2023
Q2Q % growth		 -0.15
-200.00%		-0.11-0.04-33.69%
Q1 2023
Q2Q % growth		 -0.11 -0.110.00-2.71%
Q4 2022
Q2Q % growth		 -0.10
28.57%		-0.08-0.02-30.72%
Q3 2022
Q2Q % growth		 -0.08
88.41%		-0.05-0.03-56.86%
Q2 2022
Q2Q % growth		 -0.05 -0.060.0118.30%
Q4 2021
Q2Q % growth		 -0.14 -0.03-0.11-357.52%
Q3 2021
Q2Q % growth		 -0.69 -0.07-0.62-866.39%
Q1 2021
Q2Q % growth		 -0.69 -0.04-0.65-1,591.18%
ANEB Yearly EPS VS EstimatesANEB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2 3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
ANEB Yearly Revenue VS EstimatesANEB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2031 2032 2033 50M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
RevenueN/A N/A N/A N/A